<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04744285</url>
  </required_header>
  <id_info>
    <org_study_id>I 757820</org_study_id>
    <nct_id>NCT04744285</nct_id>
  </id_info>
  <brief_title>Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers</brief_title>
  <acronym>COMET 2 3 1</acronym>
  <official_title>Effects of Filter Ventilation and Ventilation Information on Product Use Behaviors in Cigarette Smokers (COMET 2 3 1)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Roswell Park Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial collects data to see how filter ventilation and ventilation information&#xD;
      affects product use behaviors in cigarette smokers. Providing ventilation information on the&#xD;
      cigarette package may affect smokers' rating of product appeal, perceptions of health risk,&#xD;
      and changes in cigarette consumption.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To assess how adding messaging to cigarette packages about filter vents and filters&#xD;
      influences respondents awareness of filter ventilation, beliefs about the function of filter&#xD;
      vents and filters, smoking behavior, ratings of cigarette satisfaction, smoking topography,&#xD;
      exposure to nicotine and carbon monoxide, perceptions about the risk of smoking, and&#xD;
      intention to stop smoking.&#xD;
&#xD;
      OUTLINE: Participants are randomized to 1 of 4 conditions.&#xD;
&#xD;
      CONDITION I: Participants receive regular package cigarettes for 2 weeks. Participants attend&#xD;
      3 video sessions over 0.5 hour each at baseline, 1, and 2 weeks respectively for data&#xD;
      collection.&#xD;
&#xD;
      CONDITION II: Participants receive cigarettes with neutral message &quot;Nothing about this&#xD;
      product's color or name means that it will protect a smoker from the health risks of smoking&quot;&#xD;
      on package for 2 weeks. Participants attend 3 video sessions over 0.5 hour each at baseline,&#xD;
      1, and 2 weeks respectively for data collection.&#xD;
&#xD;
      CONDITION III: Participants receive cigarettes with compensation message &quot;This product has a&#xD;
      ventilated filter. Filter vents increase how deeply a smoker inhales without them knowing,&#xD;
      which can increase the health risks of smoking&quot; on package for 2 weeks. Participants attend 3&#xD;
      video sessions over 0.5 hour each at baseline, 1, and 2 weeks respectively for data&#xD;
      collection.&#xD;
&#xD;
      CONDITION IV: Participants receive cigarettes with blocking message &quot;This product has a&#xD;
      ventilated filter. Be sure not to block the vent holes with your fingers or lips, which can&#xD;
      increase the health risks of smoking&quot; for 2 weeks. Participants attend 3 video sessions over&#xD;
      0.5 hour each at baseline, 1, and 2 weeks respectively for data collection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective questionnaires of product evaluation</measure>
    <time_frame>At 2 weeks</time_frame>
    <description>Will be assessed by Duke Sensory Scale. A 9 item questionnaire with nine items that assess participants' sensory experience All questions are rated on a 7-point Likert scale (not at all to extremely).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Readiness to quit</measure>
    <time_frame>At 2 weeks</time_frame>
    <description>Will be assessed by contemplation ladder</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Withdrawal</measure>
    <time_frame>At 2 weeks</time_frame>
    <description>Will be assessed by Minnesota Tobacco Withdrawal Scale - a 15 item question scale - with scale of 0 -4, 0=Not at all - 4=Severe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of exhaled Carbon Monoxide (CO)</measure>
    <time_frame>At 2 weeks</time_frame>
    <description>level of CO measured in exhaled breath after a 15 seconds breathhold</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cigarette Smoking-Related Carcinoma</condition>
  <arm_group>
    <arm_group_label>Condition 1 (normal cigarettes)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive regular package cigarettes for 2 weeks. Participants attend 3 video sessions over 0.5 hour each at baseline, 1, and 2 weeks respectively for data collection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Condition II (cigarettes with neutral message)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive cigarettes with neutral message &quot;Nothing about this product's color or name means that it will protect a smoker from the health risks of smoking&quot; on package for 2 weeks. Participants attend 3 video sessions over 0.5 hour each at baseline, 1, and 2 weeks respectively for data collection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Condition III (cigarettes with compensation message)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive cigarettes with compensation message &quot;This product has a ventilated filter. Filter vents increase how deeply a smoker inhales without them knowing, which can increase the health risks of smoking&quot; on package for 2 weeks. Participants attend 3 video sessions over 0.5 hour each at baseline, 1, and 2 weeks respectively for data collection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Condition IV cigarettes with blocking message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive cigarettes with blocking message &quot;This product has a ventilated filter. Be sure not to block the vent holes with your fingers or lips, which can increase the health risks of smoking&quot; for 2 weeks. Participants attend 3 video sessions over 0.5 hour each at baseline, 1, and 2 weeks respectively for data collection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cigarette packaging</intervention_name>
    <description>receive normal packet cigarette</description>
    <arm_group_label>Condition 1 (normal cigarettes)</arm_group_label>
    <arm_group_label>Condition II (cigarettes with neutral message)</arm_group_label>
    <arm_group_label>Condition III (cigarettes with compensation message)</arm_group_label>
    <arm_group_label>Condition IV cigarettes with blocking message</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data capture</intervention_name>
    <description>Attend video sessions</description>
    <arm_group_label>Condition 1 (normal cigarettes)</arm_group_label>
    <arm_group_label>Condition II (cigarettes with neutral message)</arm_group_label>
    <arm_group_label>Condition III (cigarettes with compensation message)</arm_group_label>
    <arm_group_label>Condition IV cigarettes with blocking message</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Condition 1 (normal cigarettes)</arm_group_label>
    <arm_group_label>Condition II (cigarettes with neutral message)</arm_group_label>
    <arm_group_label>Condition III (cigarettes with compensation message)</arm_group_label>
    <arm_group_label>Condition IV cigarettes with blocking message</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 21-69 years old&#xD;
&#xD;
          -  Currently smoking daily, at least 5 cigarettes per day, for the past year:&#xD;
&#xD;
             * Primarily using factory-made filtered cigarettes&#xD;
&#xD;
          -  Fair and above self-rated physical health (self-rated)&#xD;
&#xD;
          -  Fair and above self-rated mental health (self-rated)&#xD;
&#xD;
          -  Not planning to quit smoking in the next 30 days&#xD;
&#xD;
          -  Able to converse, read, and write in English&#xD;
&#xD;
          -  Access to smartphone (e.g., iPhone, Android) for Ecological Momentary Assessment (EMA)&#xD;
             component&#xD;
&#xD;
          -  Access to a smartphone/tablet/computer with video capabilities and internet access for&#xD;
             remote videoconferencing (EMA check-ins)&#xD;
&#xD;
          -  No binge drinking(alcohol) or illegal drug use:&#xD;
&#xD;
             * Alcohol Use Disorders Identification Test (AUDIT)-C for alcohol; marijuana problems;&#xD;
             any use of other illicit drugs; allow for prescriptions (e.g., opiates, amphetamine)&#xD;
&#xD;
          -  Not pregnant or breastfeeding or planning to become pregnant during the study period&#xD;
&#xD;
          -  Participant must understand the investigational nature of this study and sign an&#xD;
             Independent Ethics Committee/Institutional Review Board approved written informed&#xD;
             consent form prior to receiving any study related procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Age &lt; 21 or &gt; 69&#xD;
&#xD;
               -  Using roll-your-own cigarettes or usual brand of cigarettes is unfiltered&#xD;
&#xD;
               -  Planning to quit smoking in the next 30 days&#xD;
&#xD;
               -  Adults unable to consent&#xD;
&#xD;
               -  Minors (any persons under age 21)&#xD;
&#xD;
               -  Prisoners&#xD;
&#xD;
               -  Poor physical health by self-report&#xD;
&#xD;
               -  Poor mental health by self-report:&#xD;
&#xD;
                  * Exclude Dx psychosis, Dx bipolar, K6 score indicating serious psychological&#xD;
                  distress&#xD;
&#xD;
               -  Binge drinking(alcohol) and illegal drug use&#xD;
&#xD;
               -  Pregnant or breastfeeding by self-report&#xD;
&#xD;
               -  No access to smartphone or videoconferencing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard O'Connor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Cancer Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard O'Connor</last_name>
    <phone>716-845-4517</phone>
    <email>Richard.O'Connor@roswellpark.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Roswell Park Comprehensive Cancer Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ASK RPCI</last_name>
      <phone>800-767-9355</phone>
      <email>askroswell@roswellpark.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

